Fig. 3From: Geographic variation in the intended choice of adjuvant treatments for women diagnosed with screen-detected breast cancer in QueenslandPosterior probability of excess shared component effect among adjuvant therapies at SLA level, 1997–2008. Map (a) posterior probability of excess shared component effect (less than 0.2, 0.2–0.8 and greater than 0.8) and a line plot (b) approximate number of ranked SLAs with excess shared component effect in QLDBack to article page